An Open-Label, Single-Arm, Phase Ⅱb Clinical Study of BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
Latest Information Update: 02 Dec 2025
At a glance
- Drugs Alpha galactosylceramide (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- Sponsors BioPhoenix
Most Recent Events
- 02 Dec 2025 New trial record